The Cancer Research Center of the Albert Einstein College of Medicine was established in 1972, when it involved 23 investigators. The Center now comprises 64 investigators in 8 basic science and 7 clinical departments. They are funded for their research activities at a current annual total (direct costs only) of $20,696,759, exclusive of the Cancer Center Grant itself. The research programs of the Center fall into 8 major areas: Immunooncology, Viral Oncology, Gene Expression, Receptor-Mediated Growth and Differentiation, Growth Control in Malignant Cells, Membrane Synthesis and Structure, Carcinogenic and Therapeutic Agents, and Clinical Oncology. Of the 64 cancer investigators, 25 are housed in the Chanin Cancer Research Institute. That building also houses a number of Shared Services and Facilities including an Analytical Ultrastructure Center, Barrier Mouse Facility, Fluorescent Activated Cell Sorter, and facilities for Biohazard Research, Nucleic Acid Synthesis, Hybridoma Production and Cell Culture, and Transgenic Mice and Stem Cells. A laboratory for Macromolecular Analysis and a Nuclear Magnetic Resonance Facility are housed in adjoining buildings. The budget of the Cancer Center Grant as of June 1, 1990, the last year of the present grant, will be $1,925,420. It provides salary support for 24 cancer investigators including Senior Leadership Personnel, Major Program Directors, and the Directors of Shared Facilities; seed support for incoming new investigators who have not yet obtained personal research grants; interim support for investigators who are reapplying for grant support; and partial funding for 13 shared facilities and services, shared items of equipment, an expanding Clinical Research Program, and administration. This application is a request for the renewal of this Cancer Center Support Grant for an additional 5-year period, at the level of $2,721,560 in the first year.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-24
Application #
2086127
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-06-01
Project End
1996-07-31
Budget Start
1995-06-01
Budget End
1996-07-31
Support Year
24
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Bines, Jose; Tevaarwerk, Amye J (2018) Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy. Cancer :
Mathew, Deepti; Wang, Yanhua; Van Arsdale, Anne et al. (2018) Expression of ?V-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia. Int J Gynecol Cancer 28:363-370
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Entenberg, David; Voiculescu, Sonia; Guo, Peng et al. (2018) A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Nat Methods 15:73-80
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Sharma, Yogeshwar; Liu, Jinghua; Kristian, Kathleen E et al. (2018) In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation with Bone Marrowderived Myofibroblasts or Inflammatory Cells and not Hepatocytes is Deleterious. Gene Expr :
De Martino, Daniela; Yilmaz, Emrullah; Orlacchio, Arturo et al. (2018) PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancer. Cancer Lett 439:56-65
Norwood Toro, Laura E; Wang, Yarong; Condeelis, John S et al. (2018) Myosin-IIA heavy chain phosphorylation on S1943 regulates tumor metastasis. Exp Cell Res 370:273-282
Agalliu, Ilir; Chen, Zigui; Wang, Tao et al. (2018) Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiol Biomarkers Prev 27:1168-1175
Bhargava, Ragini; Sandhu, Manbir; Muk, Sanychen et al. (2018) C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains. Nat Commun 9:2484

Showing the most recent 10 out of 1508 publications